Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jandeleit

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Diabetologia|January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetesA M D Watson, M Olukman, C Koulis, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end productsMarkus Lassila, Kwee K Seah, Terri J Allen, et al.
Diabetologia|October 29, 2015
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathyJay C Jha, Vicki Thallas-Bonke, Claudine Banal, et al.
Physiological Reports|November 5, 2014
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathyVicki Thallas-Bonke, Jay C Jha, Stephen P Gray, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Journal of Cardiovascular Translational Research|June 20, 2012
Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapiesMona Sedeek, Augusto C Montezano, Richard L Hebert, et al.
Thrombosis and Haemostasis|July 24, 2015
HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombiIngo Ahrens, Yung-Chih Chen, Danijal Topcic, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Antioxidants & Redox Signaling|September 24, 2013
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathyJennifer L Wilkinson-Berka, Devy Deliyanti, Indrajeetsinh Rana, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Diabetologia|January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetesA M D Watson, M Olukman, C Koulis, et al.
Journal of the American Society of Nephrology : JASN|July 31, 2004
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end productsMarkus Lassila, Kwee K Seah, Terri J Allen, et al.
Diabetologia|October 29, 2015
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathyJay C Jha, Vicki Thallas-Bonke, Claudine Banal, et al.
Physiological Reports|November 5, 2014
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathyVicki Thallas-Bonke, Jay C Jha, Stephen P Gray, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Journal of Cardiovascular Translational Research|June 20, 2012
Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapiesMona Sedeek, Augusto C Montezano, Richard L Hebert, et al.
Thrombosis and Haemostasis|July 24, 2015
HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombiIngo Ahrens, Yung-Chih Chen, Danijal Topcic, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Antioxidants & Redox Signaling|September 24, 2013
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathyJennifer L Wilkinson-Berka, Devy Deliyanti, Indrajeetsinh Rana, et al.
Pageof 19